Hwang Woo-suk is a South Korean veterinarian and researcher. He was a professor of theriogenology and biotechnology at Seoul National University until he was dismissed on March 20, 2006. He was considered a pioneering expert in stem cell research and even called the "Pride of Korea". However, he became infamous around November 2005 for fabricating a series of stem cell experiments that were published in high-profile journals, the case known as the Hwang affair.
Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and computational biology. The journal was established in 1974 by Benjamin Lewin and is published twice monthly by Cell Press, owned by Elsevier.
The Kennedy Institute of Ethics Journal is a quarterly academic journal established in 1991. It is published by the Johns Hopkins University Press on behalf of the Kennedy Institute of Ethics and focuses on questions of bioethics such as those relating to the research of and therapeutic use of human embryonic stem cells, organ donation, and genetic manipulation, as well as issues of global justice, research in the developing world, environmental ethics, food ethics, and issues of governance and expertise in clinical research.
Elaine V. Fuchs is an American cell biologist known for her work on the biology and molecular mechanisms of mammalian skin and skin diseases, who helped lead the modernization of dermatology. Fuchs pioneered reverse genetics approaches, which assess protein function first and then assess its role in development and disease. In particular, Fuchs researches skin stem cells and their production of hair and skin. She is an investigator at the Howard Hughes Medical Institute and the Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development at The Rockefeller University.
Shinya Yamanaka is a Japanese stem cell researcher and a Nobel Prize laureate. He is a professor and the director emeritus of Center for iPS Cell Research and Application, Kyoto University; as a senior investigator at the UCSF-affiliated Gladstone Institutes in San Francisco, California; and as a professor of anatomy at University of California, San Francisco (UCSF). Yamanaka is also a past president of the International Society for Stem Cell Research (ISSCR).
Current Biology is a biweekly peer-reviewed scientific journal that covers all areas of biology, especially molecular biology, cell biology, genetics, neurobiology, ecology, and evolutionary biology. The journal includes research articles, various types of review articles, as well as an editorial magazine section. The journal was established in 1991 by the Current Science group, acquired by Elsevier in 1998 and has since 2001 been part of Cell Press, a subdivision of Elsevier. According to Journal Citation Reports, the journal has a 2020 impact factor of 10.834. It was categorized as a "high impact journal" by the Superfund Research Program.
Cell Press is an all-science publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Cell Press was founded and is currently based in Cambridge, MA, and has offices across the United States, Europe, and Asia under its parent company Elsevier.
Stem Cell Reviews and Reports is a medical journal published quarterly by Springer Science+Business Media. It covers contemporary and emerging areas in stem cells, including embryonic and adult stem cells, and related lineage and cloning issues. The journal also publishes reviews covering basic, clinical, biotechnology, regulatory, and ethical aspects of stem cell research and applications. The journal got its current name in 2009 from Stem Cell Reviews. According to Journal Citation Reports, the journal has a 2021 impact factor of 6.692.
Bone Marrow Transplantation is a peer-reviewed medical journal covering transplantation of bone marrow in humans. It is published monthly by Nature Research. The scope of the journal includes stem cell biology, transplantation immunology, translational research, and clinical results of specific transplant protocols.
Stem cell laws are the law rules, and policy governance concerning the sources, research, and uses in treatment of stem cells in humans. These laws have been the source of much controversy and vary significantly by country. In the European Union, stem cell research using the human embryo is permitted in Sweden, Spain, Finland, Belgium, Greece, Britain, Denmark and the Netherlands; however, it is illegal in Germany, Austria, Ireland, Italy, and Portugal. The issue has similarly divided the United States, with several states enforcing a complete ban and others giving support. Elsewhere, Japan, India, Iran, Israel, South Korea, China, and Australia are supportive. However, New Zealand, most of Africa, and most of South America are restrictive.
Cell Stem Cell is a peer-reviewed scientific journal published by Cell Press, an imprint of Elsevier.
Neural Regeneration Research is a peer-reviewed scientific journal covering research on neuroregeneration and stem cells. Topics covered include neural stem cells, neural tissue engineering, gene therapy, and minimally-invasive treatment of neurodegenerative diseases. It was established in 2006 and the editors in chief are Kwok-Fai So and Xiao-Ming Xu. The journal publishes the following types of papers: research and reports, techniques and methods, investigation and analysis, meta-analyses and reviews, evidence-based case reports, and perspectives.
The Journal of Neurotrauma is a monthly peer-reviewed medical journal covering research on neurotraumas. It is an official journal of the National Neurotrauma Society and the International Neurotrauma Society. The journal was established in 1984 and is published by Mary Ann Liebert, Inc. The editor-in-chief is David L. Brody, MD, PhD.
Hossein Baharvand is an Iranian stem cell and developmental biologist. He received his B.Sc. in biology from Shiraz University in 1994, and M.Sc. in Developmental Biology from Shahid Beheshti University, Tehran in 1996. He then obtained his Ph.D. in Cell and Developmental Biology from Khwarizmi University in 2004. He first joined the Royan Institute in 1995 in which he founded Royan Institute for Stem Cell Biology and Technology.
The International Society for Stem Cell Research (ISSCR) is an independent 501(c)(3) nonprofit organization based in Evanston, Illinois, United States. The organization's mission is to promote excellence in stem cell science and applications to human health.
Regenerative Medicine is a peer-reviewed medical journal covering stem cell research and regenerative medicine. It was established in 2006 and is published by Future Medicine. The editor-in-chief is Chris Mason.
Stem Cells is a peer-review scientific journal of cell biology. It was established as The International Journal of Cell Cloning in 1983, acquiring its current title in 1993.
Stem Cell Research is a peer-reviewed open-access scientific journal covering research on stem cells. The journal was established in 2007 and is published 8 times per year by Elsevier. The editor-in-chief is Thomas Zwaka.
Cell Journal is a quarterly peer-reviewed scientific journal.The aim of the journal is to disseminate information by publishing the most recent scientific research studies based on medical and developmental biology including cell therapy and regenerative medicine, stem cell biology, reproductive medicine, medical genetics, immunology, oncology, clinical biochemistry, neuroscience, and tissue engineering. It was established in 1999 as Yakhteh Medical Journal, obtaining its current name in 2010. It is published by the Royan Institute and the editor-in-chief is Ahmad Hosseini. According to the Journal Citation Reports, the journal has a 2023 impact factor of 1.7 Cell J is an open access journal. This journal holds the membership of the Committee on Publication Ethics (COPE).
Stem Cells and Development is a biweekly peer-reviewed scientific journal covering cell biology, with a specific focus on biomedical applications of stem cells. It was established in 1992 as the Journal of Hematotherapy, and was renamed the Journal of Hematotherapy & Stem Cell Research in 1999. The journal obtained its current name in 2004. It is published by Mary Ann Liebert, Inc. and the editor-in-chief is Graham C. Parker. According to the Journal Citation Reports, the journal has a 2018 impact factor of 3.147.
